EDAP TMS S.A. Stock price

Equities

EDAP

US2683111072

Advanced Medical Equipment & Technology

Real-time Estimate Cboe BZX 01:10:34 2024-03-28 pm EDT 5-day change 1st Jan Change
7.26 USD +2.25% Intraday chart for EDAP TMS S.A. -1.89% +37.50%
Sales 2023 65.41M Sales 2024 * 71.42M Capitalization 262M
Net income 2023 -22M Net income 2024 * -9M EV / Sales 2023 2.98 x
Net cash position 2023 * - Net cash position 2024 * - EV / Sales 2024 * 3.65 x
P/E ratio 2023
-8.56 x
P/E ratio 2024 *
-25 x
Employees 264
Yield 2023 *
-
Yield 2024 *
-
Free-Float 33.38%
More Fundamentals * Assessed data
Dynamic Chart
European Equities Traded in the US as American Depositary Receipts Rise Slightly in Wednesday Trading MT
Transcript : EDAP TMS S.A., Q4 2023 Earnings Call, Mar 27, 2024
EDAP TMS S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
EDAP TMS S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Tuesday Trading MT
EDAP TMS SA Announces FDA Breakthrough Device Designation for Focal One in the Treatment of Deep Infiltrating Rectal Endometriosis CI
European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading But End Week Flat MT
European Equities Traded in the US as American Depositary Receipts Trend Lower in Thursday Trading MT
European Equities Traded in the US as American Depositary Receipts Rise Modestly in Tuesday Trading MT
European Equities Traded in the US as American Depositary Receipts Open Week Flat in Monday Trading MT
European Equities Traded in the US as American Depositary Receipts Trend Lower in Wednesday Trading MT
European Equities Traded in the US as American Depositary Receipts Move Higher in Wednesday Trading MT
European Equities Traded in the US as American Depositary Receipts Fall in Tuesday Trading MT
European Equities Traded in US as American Depositary Receipts Move Slightly Higher in Friday Trading MT
European Equities Traded in the US as American Depositary Receipts Lower in Thursday Trading MT
More news
1 day-2.74%
1 week-5.84%
Current month+12.34%
1 month+19.73%
3 months+35.63%
6 months+11.99%
Current year+34.47%
More quotes
1 week
6.81
Extreme 6.81
7.55
1 month
6.00
Extreme 5.995
7.97
Current year
5.04
Extreme 5.0375
7.97
1 year
3.60
Extreme 3.6
12.23
3 years
3.60
Extreme 3.6
12.65
5 years
1.46
Extreme 1.46
12.65
10 years
1.15
Extreme 1.15
12.65
More quotes
Managers TitleAgeSince
Chief Executive Officer - 23-04-30
Chairman 54 97-04-30
Chief Operating Officer - 20-12-31
Members of the board TitleAgeSince
Director/Board Member 62 Dec. 05
Director/Board Member 74 09-07-15
Chairman 54 97-04-30
More insiders
Date Price Change Volume
24-03-28 7.26 +2.25% 37 195
24-03-27 7.1 -2.74% 182,138
24-03-26 7.3 -1.35% 22,202
24-03-25 7.4 -0.07% 53,574
24-03-22 7.405 +0.07% 12,010

Delayed Quote Nasdaq, March 27, 2024 at 04:00 pm EDT

More quotes
Edap Tms SA is a France-based company that develops, manufactures, promotes and distributes minimally invasive medical devices for urology based upon ultrasound technology. The Company's activity is organized in two divisions: HIFU (High Intensity Focused Ultrasound) and ESWL (Extracorporeal ShockWave Lithotripsy) that invests in research and development, partnering with INSERM French public laboratory and international medical research institutions. It specialises in HIFU technology, a non-invasive treatment of prostate conditions with a range of Robotic HIFU devices, Ablatherm Fusion and Focal One, ESWL and Stone Laser that offers a range of minimally invasive solutions covering the full scope of urinary tract stone indications. It also operates worldwide via a network of corporate offices, subsidiaries and distribution partners
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
7.1 USD
Average target price
12.33 USD
Spread / Average Target
+73.71%
Consensus
  1. Stock
  2. Equities
  3. Stock EDAP TMS S.A. - Nasdaq